U-Chart Analysis:AnGes,Inc.:4563

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index AnGes,Inc. Go to web site 4563 Medicals 東証グロース December 1, 2000 2002.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

AnGes,Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

AnGes,Inc. Balance Sheet 2023年12月期 AnGes,Inc. Balance Sheet 2022年12月期 AnGes,Inc. Balance Sheet 2021年12月期 AnGes,Inc. Balance Sheet 2020年12月期 AnGes,Inc. Balance Sheet 2019年12月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Cash and Cash Equivalents 4,160 11,035 17,899 11,537 10,041
Other Current AssetsHelp 1,938 1,861 3,527 2,630 952
Tangible Fixed AssetsHelp 423 1,411 193 236 49
Intangible Fixed AssetHelp 0 0 0 0 -0
Investments and OthersHelp 802 1,259 1,161 1,238 -21,772
Total AssetsHelp 29,070 38,821 45,456 38,355 12,525
Total Current LiabilitiesHelp 2,347 7,400 6,821 5,675 469
Total Long-term LiabilitiesHelp 215 995 0 0 0
Shareholder's EquityHelp 26,508 30,425 38,635 32,680 12,055
Total LiabilitiesHelp 29,070 38,821 45,456 38,355 12,525

AnGes,Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

AnGes,Inc. Profit and Loss Account 2023年12月期 AnGes,Inc. Profit and Loss Account 2022年12月期 AnGes,Inc. Profit and Loss Account 2021年12月期 AnGes,Inc. Profit and Loss Account 2020年12月期 AnGes,Inc. Profit and Loss Account 2019年12月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Amount of Sales 153 67 64 40 327
Total Sales 153 67 64 40 327
Cost of SalesHelp 134 94 57 23 87
Other Costs and RevenueHelp 7,056 14,688 13,683 4,226 3,990
Total CostsHelp 7,189 14,782 13,740 4,250 4,078
Net RevenueHelp 19 -27 7 17 240
Earnings Before TaxHelp -7,070 -14,717 -13,735 -4,205 -3,752
Net IncomeHelp -7,036 -14,715 -13,676 -4,210 -3,751
Net Income -7,036 -14,715 -13,676 -4,210 -3,751

AnGes,Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

AnGes,Inc. Cash Flow Statement 2023年12月期 AnGes,Inc. Cash Flow Statement 2022年12月期 AnGes,Inc. Cash Flow Statement 2021年12月期 AnGes,Inc. Cash Flow Statement 2020年12月期 AnGes,Inc. Cash Flow Statement 2019年12月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Operating Cash Flow(OFC)Help -8,746 -11,214 -11,381 -2,961 -2,180
Investing Cash Flow(ICF)Help -357 -97 -155 -6,964 -1,250
Financing Cash FlowHelp 2,036 3,573 17,379 11,404 7,677
Exchange Difference of Cash and Cash EquivalentsHelp 188 873 455 18 8
Net Increase and Decrease in Cash and Cash Equivalentsn -6,878 -6,866 6,299 1,496 4,256

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

AnGes,Inc.

Company where related level is highHelp

AnGes,Inc.
MUROMACHI CHEMICALS INC.
Mochida Pharmaceutical Co.,Ltd.
Immuno-Biological Laboratories Co., Ltd.
K Pharma,Inc.
Carna Biosciences,Inc.
BrightPath Biotherapeutics Co., Ltd.
Sumitomo Pharma Co., Ltd.
Oncolys BioPharma Inc.
MIKASA SEIYAKU CO.,LTD.